DEBORAH NUNEMAKER: Open Payments
NPI 1801249859 · MONT ALTO, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,818 in 95 payments from 11 companies in 2025. Trend: 2023 $1,820 · 2024 $1,385 · 2025 $1,818
Food & beverage: $1,710Education: $108
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $397 |
| PFIZER INC. | 17 | $369 |
| Janssen Biotech, Inc. | 8 | $275 |
| ABBVIE INC. | 12 | $206 |
| Novartis Pharmaceuticals Corporation | 15 | $157 |
| AstraZeneca Pharmaceuticals LP | 6 | $116 |
| Radius Health, Inc. | 4 | $94 |
| ANI Pharmaceuticals, Inc. | 4 | $87 |
| GlaxoSmithKline, LLC. | 4 | $59 |
| Organon LLC | 2 | $45 |
Products named: XELJANZ, TREMFYA, ENBREL, COSENTYX, RINVOQ, SAPHNELO, EVENITY, PURIFIED CORTROPHIN GEL.
Industry payments across PA — which companies pay providers there.
